Effect duration of the initial course of peroneal electrical Transcutaneous NeuroModulation in patients with overactive bladder

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0110302" target="_blank" >RIV/00843989:_____/23:E0110302 - isvavai.cz</a>

Alternative codes found

RIV/61988987:17110/23:A2402NE2 RIV/00216208:11130/23:10458584 RIV/00064203:_____/23:10458584

Result on the web

<a href="https://link.springer.com/article/10.1007/s00345-023-04394-z" target="_blank" >https://link.springer.com/article/10.1007/s00345-023-04394-z</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00345-023-04394-z" target="_blank" >10.1007/s00345-023-04394-z</a>

Result language

angličtina

Original language name

Effect duration of the initial course of peroneal electrical Transcutaneous NeuroModulation in patients with overactive bladder

Original language description

Purpose: The aim of this prospective 12-month follow-up study is to evaluate the persistence of the treatment effect achieved during the initial course of peroneal electrical Transcutaneous NeuroModulation (peroneal eTNM®) in patients with overactive bladder (OAB). Methods: This study enrolled 21 female patients who participated in two previous clinical studies designed to assess the efficacy and safety of peroneal eTNM®. The patients were left without subsequent OAB treatment and were invited to attend regular follow-up visits every 3 months. The patient's request for additional treatment was considered an indicator of the withdrawal of the treatment effect of the initial course of peroneal eTNM®. The primary objective was the proportion of patients with persisting treatment effect at follow-up visit 12 months after initial course of peroneal eTNM®. Descriptive statistics are presented using median, correlation analyses were computed using a nonparametric Spearman correlation. Results: The proportion of patients with persistent therapeutic effect of the initial course of peroneal eTNM® was 76%, 76%, 62% and 48% at 3, 6, 9 and 12 months, respectively. There was a significant correlation between patient reported outcomes and the number of severe urgency episodes with or without urgency incontinence as reported by patients at each follow-up visit (p = 0.0017). Conclusion: The treatment effect achieved during the initial phase of peroneal eTNM® persists for at least 12 months in 48% of patients. It is likely that the duration of effects is dependent on the length of the initial therapy.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30217 - Urology and nephrology

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2023

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

World journal of urology

ISSN

0724-4983

e-ISSN

1433-8726

Volume of the periodical

41

Issue of the periodical within the volume

6

Country of publishing house

DE - GERMANY

Number of pages

6

Pages from-to

1629-1634

UT code for WoS article

000965128900001

EID of the result in the Scopus database

2-s2.0-85151952090